1. Abdelgany A., Wood M., and Beeson D. (2003). Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interference. Human mol. genet. 12:2637–2644
2. Anneren G., and Edman B. (1993). Down syndrome-a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of the effects from the superoxide type-1 (SOD-1) gene. AMPIS Suppl. 40:71–79
3. Antila, E., Norberg, U. R., Syvaoja, E. L., and Wetermarck, T. (eds.), (1990). Selenium therapy in down syndrome: a theory and clinical trial Antioxidants in therapy and preventative medicine. New York: Plenum Press, pp. 183–186.
4. Becker L. E., Armstrong D. L., and Chan F. (1986). Dendritic atrophy in children with Down’s syndrome. Annals neurol. 20:520–526
5. Becker L., Mito T., Takashima S., and Onodera K. (1991). Growth and development of the brain in Down syndrome. Progress Clin. Biol. Res. 373:133–152